Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human

Doriane Richard¹, Hamid Morjani, Benoît Chénais

¹Unité MéDIAN, CNRS FRE-2141, Faculté de Pharmacie, 51 rue Cognacq-Jay, Reims, France.

Leukemia Research

|August 7, 2002

Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Age-associated changes in type I collagen promote the invasion of BRAF<sup>V600E</sup> mutated melanoma cells and their resistance to targeted therapies within three-dimensional matrix models.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2025

Same author

Concordance between Tympanic and Enteral Temperature for Early Fever Detection in Hematologic Intensive Care Unit Patients: A Prospective Study.

Acta haematologica·2025

Same author

Targeted therapies overcome the poor prognosis of stereotyped Subset#2 chronic lymphocytic leukemia : a real-world multicentric study.

Leukemia·2025

Same author

Raman imaging for monitoring deuterated squalene-gemcitabine nanomedicines in single living breast cancer cells.

International journal of pharmaceutics·2024

Same author

Novel Bis-1,2,3-triazole-thiazolidinone hybrid as anticancer agents that induce apoptosis and molecular modeling study.

Future medicinal chemistry·2024

Same author

Semicarbazone, thiosemicarbazone tailed isoxazoline-pyrazole: synthesis, DFT, biological and computational assessment.

Future medicinal chemistry·2024

Aclarubicin (ACLA) at differentiating concentrations generates reactive oxygen species (ROS) in leukemia cells, driving differentiation. However, ACLA also reduces the labile iron pool (LIP) independently of ROS.

Area of Science:

Biochemistry
Cell Biology
Pharmacology

Background:

Aclarubicin (ACLA) is an anthracycline antineoplastic agent known for its differentiating effects.
Its mechanism in human solid tumors and leukemia warrants further investigation.

Purpose of the Study:

To investigate the role of reactive oxygen species (ROS) and cellular labile iron pool (LIP) in ACLA-induced differentiation.
To elucidate the molecular mechanisms underlying ACLA's action in leukemia cell lines.

Main Methods:

Dihydroethidium fluorescent probe assay to detect ROS generation.
Calcein-based spectrofluorimetric assay to measure cellular LIP.
Experiments conducted on K562 and HL-60 leukemia cell lines.

Main Results:

Related Experiment Videos

Subtoxic concentrations of ACLA induced significant ROS generation in K562 and HL-60 cells.
ACLA treatment markedly decreased the LIP in both leukemia cell lines.
ACLA-induced differentiation was ROS-dependent, while LIP reduction was ROS-independent.

Conclusions:

ACLA-induced differentiation in leukemia is mediated by ROS generation.
ACLA impacts cellular iron homeostasis by reducing LIP, a process independent of ROS.
These findings provide insights into the dual mechanism of ACLA in leukemia treatment.